|Mr. Peer Michael Schatz||CEO, MD & Member of Management Board||1.36M||N/A||1966|
|Dr. Roland Sackers||CFO, MD & Member of Management Board||692k||N/A||1969|
|Dr. Barthold Piening||Sr. VP & Head of Global Operations||N/A||N/A||1958|
|Mr. John Gilardi||VP of Corp. Communications & Investor Relations||N/A||N/A||N/A|
|Mr. Jean-Pascal Viola||Head of Corp. Bus. Devel., Intellectual Property & Litigation and Sr. VP||N/A||N/A||N/A|
QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. The company offers sample technologies for plasmid deoxyribonucleic acid (DNA) purification, ribonucleic acid purification and stabilization, genomic and viral nucleic acid purification, DNA cleanup after polymerase chain reaction (PCR) and sequencing, target enrichment, and library preparation for sequencing applications; and assay technology solutions. It also provides Ingenuity Variant Analysis, an application for analysis and interpretation of human sequencing data generated with next-generation sequencing (NGS) technologies; QIAGEN Clinical Insight, an evidence-based variant classification; CLC Genomics Workbench for the analysis and visualization of data from various NGS platforms; and GeneGlobe, a Web-based portal that enables researchers to search and order bioinformatics solutions and linking biological interpretation from pre-designed and custom PCR assay kits, NGS assay panels, and other products. In addition, the company offers instrumentation systems for laboratories. Its automation platforms include QIAsymphony, a modular system; QIAsymphony SP for sample preparation; QIAsymphony AS for assay setup; Rotor-Gene Q, a rotary real-time PCR cycler system; QIAstat-Dx for molecular analysis of common syndromes; GeneReader NGS System, a sample to insight NGS solution for laboratories; NeuMoDx 288 and NeuMoDx 96 for automation of higher-throughput PCR testing in clinical laboratories; and QIAcube and QIAcube connect workstations, which provides versatile solutions for automated sample processing; It serves molecular diagnostics, applied testing, pharma, and academia customers. QIAGEN N.V. has collaboration agreements with Ares Genetics and Laboratory Corporation of America Holdings; Inovio Pharmaceuticals Inc.; NanoCellect Biomedical, Inc.; and DiaSorin. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.
QIAGEN N.V.’s ISS Governance QualityScore as of July 29, 2019 is 3. The pillar scores are Audit: 1; Board: 1; Shareholder Rights: 9; Compensation: 5.